Timing of surgery after neoadjuvant immunochemotherapy in head and neck squamous cell carcinoma: Current evidence, surgical implications, and a research agenda
{{output}}
Significance: Perioperative immune checkpoint blockade is rapidly moving into routine care for resectable head and neck squamous cell carcinoma (HNSCC), making timing of surgery after neoadjuvant immunotherapy (NAI) and neoadjuva... ...
